MMP1 and MMP9 can be used as independent prognostic factors to predict the prognosis of breast cancer patients, in order to further study the pathological mechanism and possible treatment targets for breast cancer, especially for Her2 and Basel subtypes. The gene discussed is ERBB2; the disease is breast cancer.